. 2022; 28(4): 357-361 | DOI: 10.14744/GKDAD.2021.50455 | ||||
COVID-19 Hastalarında Gelişen Pnömotoraks Mortalite Belirteci Olabilir mi?Mesut Öterkuş1, Leman Acun Delen2, Umut Sabri Kasapoğlu31Malatya Turgut Özal Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, Malatya, Türkiye2Malatya Eğitim ve Araştırma Hastanesi, Anesteziyoloji ve Reanimasyon Kliniği, Malatya, Türkiye 3Malatya Eğitim ve Araştırma Hastanesi, Göğüs ve Yoğun Bakım Anabilim Dalı, Malatya, Türkiye Amaç: Çalışmamızda koronavirüs hastalığı-19’un (COVID-19) nadir görülen bir komplikasyonu olan pnömotoraksın mortalite üzerine etkisini araştırmayı amaçladık. Can Pneumothorax Developing in COVID-19 Patients be a Mortality Marker?Mesut Öterkuş1, Leman Acun Delen2, Umut Sabri Kasapoğlu31Department of Anaesthesiology and Reanimation, Malatya Turgut Özal University Faculty of Medicine, Malatya, Türkiye2Department of Anesthesiologia and Reanimation, Malatya Training and Research Hospital, Malatya, Türkiye 3Department of Pulmonary and Critical Care Medicine, Malatya Training and Research Hospital, Malatya, Türkiye Objectives: The purpose of this study is to investigate the effects of pneumothorax (PX), a rare complication of COVID-19, on mortality. Methods: All patients admitted to our hospital with the diagnosis of COVID-19 were screened, and patients who developed PX were included in the study. Patient demographics data, number of days of hospitalization for comorbidities, day and duration of thorax tube insertion, and laboratory findings during hospitalization were recorded by scanning the hospital automation system and patient records. Mesut Öterkuş, Leman Acun Delen, Umut Sabri Kasapoğlu. Can Pneumothorax Developing in COVID-19 Patients be a Mortality Marker?. . 2022; 28(4): 357-361 Sorumlu Yazar: Mesut Öterkuş, Türkiye |
|